ETHYL 2-(5-BROMOTHIAZOL-2-YL)ACETATE, 95.0%, 250mg

1-METHYL-1H-PYRROLO[2,3-B]PYRIDIN-6-AMINE, 95.0%, 5g

2-Bromo-6-iodo-4-(trifluoromethyl)aniline, 95.0%, 1g

3-(Pyrrolidin-1-ylsulfonyl)pyridine, 95.0%, 1g

(3,4-Difluorophenyl)acetic acid ethyl ester, 99.0%, 250mg

1-Heptanesulfonic acid, sodium salt, 98.0%, 500g

(E)-4-HYDROXY-N'-(4-ISOPROPYLBENZYLIDENE)BENZOHYDRAZIDE, 95.0%, 25mg

3'-Azido-2'3'-ddGTP, ≥95%, 10 µl, plastic packaging.

N-Methyl-1-(p-tolyl)methanamine hydrochloride, 95.0%, 5g

(2E)-3-(5-methylfuran-2-yl)-1-(4-nitrophenyl)prop-2-en-1-one, 95.0%, 2g

2-Fluoro-3-(hydroxymethyl)-5-methylpyridine, 97%, 250mg

(4-(Cyclohexylmethoxy)phenyl)boronic acid, 98+%, 100mg

2-(3,5-Bis(trifluoromethyl)phenyl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane, 95.0%, 5g